Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histocompatibility studies in pre-eclampsia.

D C Kilpatrick1, W A Liston, E C Jazwinska

  • 1Blood Transfusion Centre, Royal Infirmary, Edinburgh, Scotland.

Tissue Antigens
|May 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can ficolin-2 (L-ficolin) insufficiency be established by a single serum protein measurement?

International journal of immunogenetics·2015
Same author

Drug modification of LPS-stimulated human monocyte-derived dendritic cells.

British journal of biomedical science·2012
Same author

Mechanisms and assessment of mitogenesis : an overview.

Methods in molecular medicine·2011
Same author

Use of lectins as mitogens for lymphocytes.

Methods in molecular medicine·2011
Same author

Maternal obesity, length of gestation, risk of postdates pregnancy and spontaneous onset of labour at term.

BJOG : an international journal of obstetrics and gynaecology·2008
Same author

MBL really binds to healthy human cells!

Scandinavian journal of immunology·2007
Same journal

Corrigendum.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update September 2015.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update August 2015.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update July 2015.

Tissue antigens·2015
Same journal

Four amino acid exchanges located in the alpha-2 domain specify the novel HLA-B*50:20 allele.

Tissue antigens·2015
Same journal

A novel HLA-A*02 variant, HLA-A*02:575, detected in a Taiwanese bone marrow hematopoietic stem cell donor.

Tissue antigens·2015
See all related articles

Severe pre-eclampsia is linked to a higher frequency of the HLA-DR4 antigen in mothers and neonates. This genetic association was observed when comparing severe pre-eclampsia families to healthy controls.

Area of Science:

  • Immunogenetics
  • Reproductive Medicine
  • Human Genetics

Background:

  • Pre-eclampsia is a serious pregnancy complication characterized by high blood pressure and potential organ damage.
  • The role of human leukocyte antigen (HLA) genes in pre-eclampsia susceptibility is an area of ongoing research.
  • Previous studies have explored associations between various HLA types and pre-eclampsia, with mixed results.

Purpose of the Study:

  • To investigate the association between specific HLA-A, HLA-B, and HLA-DR types and the risk of developing severe and mild pre-eclampsia.
  • To compare HLA antigen frequencies, homozygosity, sharing, and lymphocytotoxin production in families affected by pre-eclampsia versus normotensive controls.

Main Methods:

  • Human Leukocyte Antigen (HLA) typing for HLA-A, HLA-B, and HLA-DR was performed on mothers, fathers, and neonates from three groups: severe pre-eclampsia, mild pre-eclampsia, and normal pregnancies.

Related Experiment Videos

  • Statistical analysis was used to compare HLA antigen frequencies and other genetic markers between the groups.
  • Relative risk calculations were performed to assess the strength of observed associations.

    • Main Results:

    • A statistically significant increase in the frequency of the HLA-DR4 antigen was found in both mothers and neonates from families with severe pre-eclampsia compared to normotensive controls (relative risk 3.6, p < 0.003).
    • No significant differences were observed between pre-eclampsia groups and controls regarding HLA antigen homozygosity, HLA antigen sharing, or lymphocytotoxin production.

    Conclusions:

    • The HLA-DR4 antigen may represent a genetic risk factor for severe pre-eclampsia, potentially influencing susceptibility in both mothers and neonates.
    • Further research is warranted to elucidate the specific mechanisms by which HLA-DR4 might contribute to the pathophysiology of severe pre-eclampsia.